Recombinant Human HSP90 Protein，His

HSP90, or Heat Shock Protein 90, is a highly conserved molecular chaperone that plays a crucial role in protein folding, stability, and regulation within the cell. It is involved in the maturation and activation of various signaling proteins, including receptor tyrosine kinases and steroid hormone receptors, which are essential for normal cellular functions and responses to stress. Given its central role in numerous cellular processes, HSP90 has emerged as a significant target for cancer therapy, as many oncogenic proteins are dependent on HSP90 for their stability and functionality. Researchers have focused on generating recombinant HSP90 proteins to study its structure, function, and interactions with client proteins in more detail. Recombinant HSP90 allows for the examination of its biochemical properties, post-translational modifications, and interactions in controlled experimental settings, enabling a deeper understanding of its role in oncogenesis and cellular stress responses. Furthermore, the development of HSP90 inhibitors has opened new avenues for therapeutic intervention in cancer treatment. The ongoing study of HSP90 and its recombinant forms is thus vital for elucidating its complex biology and for identifying potential strategies to manipulate its activity in disease contexts, particularly in cancer and neurodegenerative disorders.